-
Opinions on the consequences of marijuana use are wide-ranging: Some experts express grave concern that it may induce COPD, increase risk of lung cancer, promote the emergence of schizophrenia, and lead to "heavy drug" use; others essentially dismiss these (potential) adversities as inadequately established to permit accusations that marijuana has any commonplace serious adverse effects.
-
The FDA has extended the approval for the Human Papillomavirus Quadrivalent Recombinant Vaccine to include the prevention of vaginal and vulvar cancer. The vaccine, originally approved in 2006, is already approved for the prevention of cervical cancer and genital warts.
-
Among almost 6000 patients with COPD who were using other classes of respiratory therapies, the addition of tiotropium, compared with placebo, was associated with improvements in lung function, quality of life, and exacerbations during a 4-year period, but did not result in benefits in the rate of decline in FEV1.
-
If your adolescent patients are not using condoms for protection, are you exploring the reasons behind such decisions? Results of a just-published survey of more than 1,400 adolescents and young adults indicate that teens who don't use condoms were significantly more likely to believe that condoms reduce sexual pleasure and also were more concerned that their partner would not approve of condom use.
-
Nearly 24% of U.S. women are affected with one or more pelvic floor disorders, report researchers funded by the National Institutes of Health (NIH).1 The analysis is the first to document the extent of such conditions in a nationally representative sample.
-
According to a new report released by the Guttmacher Institute, the rate of abortion in the United States is at its lowest level since 1974.1 However, this overall trend masks large disparities in rates of unintended pregnancy and abortion across demographic subgroups.
-
Black women who undergo tubal sterilization to prevent future pregnancies are more likely than their white counterparts to regret the decision, results from a new study indicate.
-
-
The authors provide a mini-primer on interstitial cystitis (IC), a condition that is known to be poorly diagnosed and treated in many circumstances.
-
Miller and colleagues, representing 29 study centers in the United States, reported the results of a Phase 2 clinical trial, assessing the impact of denosumab on bone density.